Literature DB >> 9323277

Compliance with cyclosporine in adolescent renal transplant recipients.

D L Blowey1, D Hébert, G S Arbus, R Pool, M Korus, G Koren.   

Abstract

Inadequate compliance with prescribed medication regimens in children is complex and poorly understood. We measured the extent and pattern of noncompliance with cyclosporine in our adolescent renal transplant population and attempted to determine factors associated with poor compliance. After informed consent, each patient was provided cyclosporine capsules in a medication bottle equipped with an electronic monitoring device (MEMS-4) in the lid. Of the 24 patients eligible, 19 patients (8 female, 11 male) completed the study. Four (21%) patients took less than 80% of the prescribed cyclosporine doses. Five (26%) patients took drug holidays involving > or = consecutive doses. There was a trend towards improved compliance with the evening dose (88.5% vs. 93.4%, P = 0.09) and a downward trend in compliance over the course of the study (P = 0.17). None of the variables tested were found to be associated with noncompliance. Experienced physicians and nurses were able to identify 2 of the 4 individuals who were identified by MEMS as noncompliant. Additionally, 2 of the 4 noncompliance patients demonstrated low cyclosporine trough levels (< 50 ng/ml). Noncompliance with cyclosporine regimens occurs commonly in adolescent renal transplant recipients. Unexpectedly low cyclosporine levels are strongly suggestive of noncompliance, whereas other variables, including prediction by physicians and nurses intimately involved in the care, were not reflective of noncompliance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323277     DOI: 10.1007/s004670050335

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

Review 1.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

Review 2.  Electronic measurement of medication adherence in pediatric chronic illness: a review of measures.

Authors:  Lisa M Ingerski; Elizabeth A Hente; Avani C Modi; Kevin A Hommel
Journal:  J Pediatr       Date:  2011-07-01       Impact factor: 4.406

Review 3.  Prevention and treatment of hepatitis C in injection drug users.

Authors:  Brian R Edlin
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 4.  Adherence to medical recommendations and transition to adult services in pediatric transplant recipients.

Authors:  Eyal Shemesh; Rachel A Annunziato; Ronen Arnon; Tamir Miloh; Nanda Kerkar
Journal:  Curr Opin Organ Transplant       Date:  2010-06       Impact factor: 2.640

5.  Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States of America.

Authors:  Maria E Ferris; Debbie S Gipson; Paul L Kimmel; Paul W Eggers
Journal:  Pediatr Nephrol       Date:  2006-05-06       Impact factor: 3.714

6.  Inferior allograft outcomes in adolescent recipients of renal transplants from ideal deceased donors.

Authors:  Matthew H Levine; Peter P Reese; Alexander Wood; Jorge H Baluarte; Ari Huverserian; Ali Naji; Peter L Abt
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

Review 7.  Problems and pitfalls of transition from paediatric to adult renal care.

Authors:  Alan R Watson
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

Review 8.  Drug compliance in adolescents: assessing and managing modifiable risk factors.

Authors:  Betty Staples; Terrill Bravender
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  The challenges of using medication event monitoring technology with pediatric transplant patients.

Authors:  Diana A Shellmer; Nataliya Zelikovsky
Journal:  Pediatr Transplant       Date:  2007-06

Review 10.  Current issues in pediatric medication adherence.

Authors:  Doreen Matsui
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.